Latest News

Under the definitive agreement, which both companies’ boards unanimously approved, Vertex will pay US$85.00 in cash for each outstanding Crinetics share.

By earning the certification, Royal Bahrain Hospital joins a select group of healthcare institutions across the Arab region recognised for placing patient experience at the centre of healthcare delivery.

The procedure was successfully carried out on a 55-year-old patient with multiple myeloma and signals the launch of the hospital’s new Stem Cell Transplantation and Cellular Therapy Program.

MedSahra connects medical equipment suppliers, healthcare providers, logistics companies, service providers, investors, technology firms, and business advisers through one platform.

Through the partnership, the two organisations aim to bridge academic knowledge with clinical expertise while supporting innovation, talent development and improved healthcare delivery.

The agreement builds on Haleon’s existing use of Microsoft 365 Copilot and broadens the company’s adoption of Microsoft’s AI, cloud and data technologies.

Tregzi, also known as Orca-T, is an engineered allogeneic cell therapy used alongside matched-donor hematopoietic stem cell transplantation.

The expanded label is expected to make about 5,500 additional children in the United States eligible for treatment.

The acquisition centres on potravitug, a Phase II monoclonal antibody developed to treat BK polyomavirus-associated nephropathy (BKPyVAN).

The acquisition gives Zimmer Biomet full ownership of the iovera° system, an FDA-cleared medical device that relieves pain without medication.